Off the newswires, Diamyd phase II test show it helps maintain beta cell production longer.
Diamyd Medical: Diamyd Announces Completion of Type 1 Diabetes Vaccine Trial with Long Term Efficacy Demonstrated at 30 Months
http://www.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20080120005105&newsLang=en
Subscribe to:
Post Comments
(
Atom
)
Posts
Oh, CRAP! Two and a half years too late for us.... I wonder if this vaccine can be used in conjunction with an islet transplant (such as the encapsulated porcine islets being trialed by Bob Elliot)? Or to reduce rejection in newly transplanted islets from any other source?
ReplyDelete